PMA device
Guardian Rt
Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Jul 18, 2005, newest Dec 27, 2006Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
11
Naming "Guardian Rt"
MAUDE reports
0
Brand "Guardian Rt", since 2015
PubMed studies
23
Mentioning "Guardian Rt"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Guardian Rt
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- GUARDIAN RTPMA supplement
P980022-S014 · Decided Dec 27, 2006 · 365 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- GUARDIAN RTPMA supplement
P980022-S012 · Decided Aug 24, 2005 · 177 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- GUARDIAN RT CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P980022-S011 · Decided Jul 18, 2005 · 332 days after receipt · Panel Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Guardian Rt", any status and sponsor, newest update first.
BioTeke USA, LLCNot on our public-company list
NCT05334758 · 282 participants · Start May 12, 2022 · Primary completion Jul 25, 2022
Device: Bio-Self COVID-19 Antigen Home Test; Standard of Care COVID-19 Test · For: COVID-19
Sites: Miami, Florida; Tallahassee, Florida; Elkridge, Maryland
University of PennsylvaniaAcademic, hospital or other
NCT01474889 · 37 participants · Start Oct 2011 · Primary completion May 2016
Device: RT-CGM · For: Hypoglycemia Unawareness; Type 1 Diabetes; Healthy
Sites: Philadelphia, Pennsylvania · 3 sites in all
- Comparison of Real-time CGMS With Intermittently-scanned CGMS in Adolescents and Adults With Type 1 Diabetes MellitusStatus unknown
Post Graduate Institute of Medical Education and Research, ChandigarhAcademic, hospital or other
NCT05928260 · 80 participants (planned) · Start Aug 10, 2023 · Primary completion Mar 2024
Device: Medtronic Guardian Connect Sensor 3; Abott Freestyle Libre Sensor · For: Type1 Diabetes Mellitus
Sites: Chandigarh, India
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Guardian Rt", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Guardian Rt"[tiab]. The summary above synthesizes these.
- The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes.
Diabetes Technol Ther · 2008Evaluation Study, Research Support, N.I.H., Extramural
- Clinical use of real-time continuous glucose monitoring.
Battelino T, Bolinder J · Curr Diabetes Rev · 2008Review
- Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy.
Clarke WL, Kovatchev B · J Diabetes Sci Technol · 2007
- Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.
Keenan DB, Mastrototaro JJ, Voskanyan G, et al. · J Diabetes Sci Technol · 2009Review
- [Therapeutic education and continuous glucose monitoring in insulin-treated diabetic patients].
Thielen V, Radermecker RP, Renard E, et al. · Rev Med Suisse · 2010English Abstract
- Measurement delay associated with the Guardian RT continuous glucose monitoring system.
Wei C, Lunn DJ, Acerini CL, et al. · Diabet Med · 2010Research Support, Non-U.S. Gov't
- Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring.
Thielen V, Scheen A, Bringer J, et al. · Diabetes Metab · 2010Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.
Kovatchev BP, Breton M, Man CD, et al. · J Diabetes Sci Technol · 2009Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU.
Kopecký P, Mráz M, Bláha J, et al. · Biomed Res Int · 2013Research Support, Non-U.S. Gov't
- Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump.
Radermecker RP, Saint Remy A, Scheen AJ, et al. · Diabetes Metab · 2010Research Support, Non-U.S. Gov't
- Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery.
Piper HG, Alexander JL, Shukla A, et al. · Pediatrics · 2006Clinical Trial, Research Support, Non-U.S. Gov't
- Diabetes research in children network:availability of protocol data sets.
Ruedy KJ, Beck RW, Xing D, et al. · J Diabetes Sci Technol · 2007
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.